CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Increase (Decrease) in Other Operating Assets and Liabilities, Net
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $20.34 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-08-05
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-06-27 was $11.81M, a 55.02% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-28 was $8.52M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-27 was -$33.71M, a 364.23% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-27 was $43.07M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was $31.57M, a 39.28% decline from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was $51.99M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was -$38.64M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was -$33.24M.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | $11.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $20.34M 10-Q · filed 2026-08-05 | -$13.38M derived: sum of 3 quarters · filed 2026-08-05 | $29.70M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-28 | $8.52M 10-Q · filed 2026-05-07 | -$25.19M derived: sum of 2 quarters · filed 2026-05-07 | $17.88M derived: sum of 3 quarters · filed 2026-05-07 | $44.15M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-27 | -$33.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $9.36M derived: sum of 2 quarters · filed 2026-02-18 | $35.62M derived: sum of 3 quarters · filed 2026-08-05 | $31.57M 10-K · filed 2026-02-18 | ||||
| 2025-09-27 | $43.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $69.34M derived: sum of 2 quarters · filed 2026-08-05 | $65.28M 10-Q · filed 2025-11-05 | $78.04M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-28 | $26.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $22.21M 10-Q · filed 2026-08-05 | $34.97M derived: sum of 3 quarters · filed 2026-08-05 | $27.55M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-29 | -$4.05M 10-Q · filed 2026-05-07 | $8.71M derived: sum of 2 quarters · filed 2026-05-07 | $1.28M derived: sum of 3 quarters · filed 2026-05-07 | $14.92M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-28 | $12.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $5.34M derived: sum of 2 quarters · filed 2026-02-18 | $18.97M derived: sum of 3 quarters · filed 2026-02-18 | $51.99M 10-K · filed 2026-02-18 | ||||
| 2024-09-28 | -$7.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.21M derived: sum of 2 quarters · filed 2025-11-05 | $39.24M 10-Q · filed 2025-11-05 | -$7.34M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2024-06-29 | $13.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $46.66M 10-Q · filed 2025-08-06 | $77.00K derived: sum of 3 quarters · filed 2026-02-18 | $2.81M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2024-03-30 | $33.02M 10-Q · filed 2025-05-07 | -$13.56M derived: sum of 2 quarters · filed 2026-02-18 | -$10.83M derived: sum of 3 quarters · filed 2026-02-18 | $6.61M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2023-12-30 | -$46.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | -$43.85M derived: sum of 2 quarters · filed 2026-02-18 | -$26.41M derived: sum of 3 quarters · filed 2026-02-18 | -$38.64M 10-K · filed 2026-02-18 | ||||
| 2023-09-30 | $2.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $20.17M derived: sum of 2 quarters · filed 2024-11-06 | $7.94M 10-Q · filed 2024-11-06 | -$27.34M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-07-01 | $17.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $5.21M 10-Q · filed 2024-08-07 | -$30.07M derived: sum of 3 quarters · filed 2025-02-19 | -$27.67M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-04-01 | -$12.23M 10-Q · filed 2024-05-09 | -$47.51M derived: sum of 2 quarters · filed 2025-02-19 | -$45.11M derived: sum of 3 quarters · filed 2025-02-19 | -$33.97M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2022-12-31 | -$35.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | -$32.88M derived: sum of 2 quarters · filed 2025-02-19 | -$21.74M derived: sum of 3 quarters · filed 2025-02-19 | -$33.24M 10-K · filed 2025-02-19 | ||||
| 2022-09-24 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $13.54M derived: sum of 2 quarters · filed 2023-11-08 | $2.04M 10-Q · filed 2023-11-08 | $15.05M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-25 | $11.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$360.00K 10-Q · filed 2023-08-09 | $12.65M derived: sum of 3 quarters · filed 2024-02-14 | $10.73M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-26 | -$11.50M 10-Q · filed 2023-05-11 | $1.51M derived: sum of 2 quarters · filed 2024-02-14 | -$409.00K derived: sum of 3 quarters · filed 2024-02-14 | $17.08M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-25 | $13.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $11.09M derived: sum of 2 quarters · filed 2024-02-14 | $28.58M derived: sum of 3 quarters · filed 2024-02-14 | -$2.01M 10-K · filed 2024-02-14 | ||||
| 2021-09-25 | -$1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $15.57M derived: sum of 2 quarters · filed 2022-11-02 | -$15.02M 10-Q · filed 2022-11-02 | $16.42M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-26 | $17.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$13.10M 10-Q · filed 2022-08-03 | $18.34M derived: sum of 3 quarters · filed 2023-02-22 | -$3.77M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-27 | -$30.58M 10-Q · filed 2022-05-04 | $851.00K derived: sum of 2 quarters · filed 2023-02-22 | -$21.26M derived: sum of 3 quarters · filed 2023-02-22 | -$26.72M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-26 | $31.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $9.32M derived: sum of 2 quarters · filed 2023-02-22 | $3.87M derived: sum of 3 quarters · filed 2023-02-22 | $1.10M 10-K · filed 2023-02-22 | ||||
| 2020-09-26 | -$22.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$27.57M derived: sum of 2 quarters · filed 2021-11-03 | -$30.34M 10-Q · filed 2021-11-03 | -$39.16M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-27 | -$5.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$8.22M 10-Q · filed 2021-08-04 | -$17.05M derived: sum of 3 quarters · filed 2022-02-16 | -$43.12M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-28 | -$2.77M 10-Q · filed 2021-05-04 | -$11.59M derived: sum of 2 quarters · filed 2022-02-16 | -$37.66M derived: sum of 3 quarters · filed 2022-02-16 | -$25.14M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-28 | -$8.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$34.90M derived: sum of 2 quarters · filed 2022-02-16 | -$22.38M derived: sum of 3 quarters · filed 2022-02-16 | -$17.25M 10-K · filed 2022-02-16 | ||||
| 2019-09-28 | -$26.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$13.55M derived: sum of 2 quarters · filed 2020-10-29 | -$8.42M 10-Q · filed 2020-10-29 | -$1.60M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-29 | $12.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $17.65M 10-Q · filed 2020-08-05 | $24.47M derived: sum of 3 quarters · filed 2021-02-17 | $53.75M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-30 | $5.13M 10-Q · filed 2020-05-07 | $11.94M derived: sum of 2 quarters · filed 2021-02-17 | $41.23M derived: sum of 3 quarters · filed 2021-02-17 | $39.26M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2018-12-29 | $6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $36.10M derived: sum of 2 quarters · filed 2021-02-17 | $34.13M derived: sum of 3 quarters · filed 2021-02-17 | $33.72M 10-K · filed 2021-02-17 | $24.75M 10-K · filed 2019-02-13 | |||
| 2018-09-29 | $29.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $27.31M derived: sum of 2 quarters · filed 2019-11-06 | $26.90M 10-Q · filed 2019-11-06 | $9.20M derived: sum of 4 quarters · filed 2020-02-11 | ||||
| 2018-06-30 | -$1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$2.38M 10-Q · filed 2019-07-31 | -$20.08M derived: sum of 3 quarters · filed 2020-02-11 | -$19.74M derived: sum of 4 quarters · filed 2020-02-11 | ||||
| 2018-03-31 | -$407.00K 10-Q · filed 2019-05-07 | -$18.11M derived: sum of 2 quarters · filed 2020-02-11 | -$17.77M derived: sum of 3 quarters · filed 2020-02-11 | -$27.00M derived: sum of 4 quarters · filed 2020-02-11 | ||||
| 2017-12-30 | -$17.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | -$17.36M derived: sum of 2 quarters · filed 2020-02-11 | -$26.59M derived: sum of 3 quarters · filed 2020-02-11 | -$15.79M 10-K · filed 2020-02-11 | -$7.32M 10-K · filed 2018-02-13 | |||
| 2017-09-30 | $340.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$8.89M derived: sum of 2 quarters · filed 2018-11-07 | $1.91M 10-Q · filed 2018-11-07 | $26.47M 10-Q · filed 2017-11-09 | -$9.32M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-07-01 | -$9.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $1.57M 10-Q · filed 2018-08-08 | $11.80M 10-Q · filed 2017-08-09 | -$9.66M derived: sum of 3 quarters · filed 2019-02-13 | $1.32M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-04-01 | $10.80M 10-Q · filed 2018-05-10 | $10.68M 10-Q · filed 2017-05-10 | -$432.00K derived: sum of 2 quarters · filed 2019-02-13 | $10.55M derived: sum of 3 quarters · filed 2019-02-13 | $1.88M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2016-12-31 | -$11.23M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$253.00K derived: sum of 2 quarters · filed 2019-02-13 | -$8.92M derived: sum of 3 quarters · filed 2019-02-13 | $2.65M 10-K · filed 2019-02-13 | -$11.93M 10-K · filed 2018-02-13 | |||
| 2016-09-24 | $10.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.31M derived: sum of 2 quarters · filed 2017-11-09 | $13.88M 10-Q · filed 2017-11-09 | |||||
| 2016-06-25 | -$8.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.90M 10-Q · filed 2017-08-09 | ||||||
| 2016-03-26 | $11.56M 10-Q · filed 2017-05-10 | |||||||
| 2015-12-26 | -$32.23M 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |